Loan & DebtMay 12, 2026, 04:14 PM
OptimizeRx Secures $35M Credit Facility; Q1 Revenue $19.8M
AI Summary
OptimizeRx Corp. secured a new $35.0 million senior secured credit facility with Fifth Third Bank, comprising a $10.0 million revolving credit facility and a $25.0 million term loan. This refinancing is expected to generate approximately $1.5 million in annual interest expense savings and replaces the existing term loan. For Q1 2026, the company reported revenue of $19.8 million, a GAAP net loss of $(0.5) million, and adjusted EBITDA of $3.3 million. OptimizeRx updated its fiscal year 2026 revenue guidance to $95-$100 million, while maintaining adjusted EBITDA guidance at $21-$25 million.
Key Highlights
- OptimizeRx secured a new $35.0 million senior secured credit facility.
- The facility includes a $10.0 million revolving credit and $25.0 million term loan.
- Expected annual interest expense savings of approximately $1.5 million.
- Q1 2026 revenue decreased 10% to $19.8 million.
- Q1 2026 GAAP net loss narrowed to $(0.5) million.
- Q1 2026 adjusted EBITDA increased to $3.3 million.
- Updated 2026 revenue guidance to $95-$100 million.
- Operating efficiency initiatives target $3 million annualized savings.